Avantor signals 2025 growth with mid-to-high single-digit bioprocessing projections and $300M cost savings target
Q4 2024 Management View Michael Stubblefield, CEO, highlighted Avantor's return to growth in Q4 2024 with low single-digit organic growth and strong bioprocessing performance, achieving high ...
Victory Capital sees organic growth acceleration with Amundi acquisition and ETF expansion
Q4 2024 Management View CEO David Brown highlighted record performance metrics, including $1.45 adjusted earnings per diluted share for the quarter, up 26% year-over-year. Total client assets reached ...